bel logo.jpg
Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares
August 03, 2021 08:42 ET | Bel Fuse Inc.
JERSEY CITY, N.J., Aug. 03, 2021 (GLOBE NEWSWIRE) -- BEL FUSE INC. (NASDAQ:BELFA) and (NASDAQ:BELFB) today announced that its Board of Directors has declared regular quarterly cash dividends of...
cons_water-logo PNG.png
Consolidated Water Sets Second Quarter 2021 Earnings Conference Call for Tuesday, August 17, 2021 at 11:00 a.m. ET
August 03, 2021 08:31 ET | Consolidated Water Co. Ltd.
GEORGE TOWN, Grand Cayman, Cayman Islands, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading developer and operator of advanced water...
IPWR.png
Ideal Power Signs B-TRAN™ Test and Evaluation Agreement with Top 10 Global Provider of Power Conversion Solutions to the Solar Industry
August 03, 2021 08:30 ET | Ideal Power Inc.
AUSTIN, Texas, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Ideal Power Inc. (Nasdaq: IPWR), pioneering the development and commercialization of highly efficient and broadly patented B-TRAN™ bi-directional...
XpresSpa Group.jpg
XpresSpa Group Announces New Pilot Program in Collaboration with EL AL Israel Airlines for Pre-Flight COVID-19 Variant Testing Through XpresCheck Testing Facilities
August 03, 2021 08:30 ET | XpresSpa Group, Inc.
NEW YORK, Aug. 03, 2021 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness company, today announced a collaboration between XpresCheck and...
Foghorn®-logo-color.jpg
Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference
August 03, 2021 08:30 ET | Foghorn Therapeutics, Inc.
CAMBRIDGE, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines targeting genetically...
Orgenesis Logo.jpg
Orgenesis Schedules Second Quarter 2021 Business Update Conference Call
August 03, 2021 08:30 ET | Orgenesis Inc.
GERMANTOWN, Md., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene...
ABVC BioPharma, Inc. Announces Pricing of $6.875 Million Firm Commitment Offering
August 03, 2021 08:30 ET | ABVC BioPharma, Inc.
FREMONT, CA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology,...
Cassava 2.png
Cassava Sciences Reports Second Quarter 2021 Financial Results
August 03, 2021 08:30 ET | Cassava Sciences, Inc.
AUSTIN, Texas, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced financial results for...
albireo logo.jpg
Albireo to Present at the 2021 Wedbush PacGrow Virtual Healthcare Conference
August 03, 2021 08:30 ET | Albireo Pharma, Inc.
BOSTON, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President and...
logo_343x193.png
Yield10 Bioscience to Announce Second Quarter 2021 Financial Results and Host a Conference Call on Wednesday, August 11, 2021
August 03, 2021 08:30 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its second quarter 2021...